Australia has an outstanding record in reproductive biology research and clinical translation commencing with the first child born by in vitro fertilization (IVF) in 1980 (2 years after Steptoe's and Edward's original IVF success in the UK) and the first live birth from a frozen IVF embryo in 1983 ( Leeton, 2004) . Today, approximately 2% of births in Australia involve some form of assisted reproductive technology.
The techniques that are essential for assisted reproductive technology, including human egg collection and the creation and freezing of embryos, are also the core methodologies by which human embryonic stem cells are isolated. The Australian government's commitment to human embryonic stem cell research seemed assured in 2002 with the award of $98.5 million in federal grants to establish the Australian Stem Cell Centre in Melbourne. The center conducts research on both embryonic and adult stem cells, tissue repair, and immune modulation. Simultaneously, the Australian parliament began debating legislation to regulate the use of human embryos in research. Legislation was enacted that allowed the granting of licenses to use surplus IVF embryos for research but banned somatic cell nuclear transfer (SCNT) (Wilmut et al., 1997) , a technique that can be used to generate patient-specific human embryonic stem cell lines for the study of different diseases. Since 2002, only nine licenses for experimentation involving human embryos have been issued: five for further development of assisted reproductive technologies and four for derivation of new human embryonic stem cell lines.
As part of this legislation, the Australian government commissioned an independent committee chaired by former federal judge John Lockhart to review the effects of these regulations on assisted reproduction and on research efforts and their possible therapeutic applications. After reviewing over 1000 submissions and international practices and after extensive discussions with state governments, other stakeholders, and the community, the Lockhart Review committee produced 54 recommendations for the government to consider and proposed amending current legislation to allow SCNT under license and following strict guidelines (Australian Government, 2005) .
A key observation of the Lockhart Review was that there is no single societal view on research using human embryos. Rather, such research encompasses many questions of fundamental scientific, religious, and moral importance. There are many strongly held, and often entrenched positions, and the reality is that very few of the opponents or proponents would be expected to change their minds. Because of these divergent views, the committee accepted that some disagreement would remain, whether or not any changes were made to the existing legislation. However, the committee also noted broad community support for medical research and for clinically assisting people to have children, even though this process involves the "wastage" of some embryos. The Lockhart Review argued that even though some people think that an activity is unethical, it does not follow that such an activity should be illegal. The committee considered that the wider the range of ethical views on a particular activity, the weaker the case for declaring that activity illegal. SCNT was highlighted as the Rubicon over which public opinion was divided. The Lockhart Review recognized that apart from outright support or outright opposition, there were three major arguments concerning SCNT that the government needed to consider.
" A conscience vote of individual parliamentarians in the Australian government last month regarding amendments to current legislation regulating human embryonic stem cell research yielded a surprising outcome. Despite opposition by the Australian Prime Minister, the Senate and House of Representatives voted to adopt the recommendations of the Lockhart Review and approve human somatic cell nuclear transfer, thus providing a consistent national policy for all researchers in Australia.
ity, under certain (prohibited) conditions, of developing into humans. However, the committee stated that the question of intent was important. Under these circumstances there was no intent to create a human but rather a collection of cells that are identical to, and therefore an extension of, the tissues of the donor. Further, the committee took the view that the moral significance of cloned embryos that are not implanted is more linked to their potential for research into treatments for serious diseases and not their potential as human lives. The committee recognized that this view is supported by many people but is also unacceptable to many others. "Community support for medical research and acceptance of processes aimed at assisting people to have children." The current use and wide acceptance of assisted reproductive technologies means that excess human embryos are currently created knowing that those not used for procreation are destined for destruction. A number of Australian states require the destruction of surplus IVF embryos after 5 or 10 years. These embryos are allowed, under current strict legal guidelines, to be used for both IVF and stem cell research. The committee regarded as inconsistent the position of accepting one destructive use and denying another, particularly when both uses aim to alleviate medical conditions, either infertility or a range of serious diseases.
"The slippery slope." Although SCNT may be intended for good, for example, to produce patient-specific human embryonic stem cell lines for studying different diseases (therapeutic cloning), it could also be used for unethical purposes, for example, to produce live born humans from embryos generated by SCNT (reproductive cloning). One argument put forward to the committee was that allowing the former will inevitably lead to the latter. However, the Lockhart Review committee had already recommended that human reproductive cloning should continue to be prohibited on the grounds of both ethics and safety, • • and so the "slippery slope" argument was rejected. The committee did note that when considering currently prohibited practices involving embryos (including embryos created by SCNT or other methods not involving fertilization of eggs by sperm or embryos with genetic material from more than two people) the strongest community objection was to the implantation of such embryos into a woman's body or to their development beyond 14 days. Thus, the committee recommended that a number of currently prohibited practices involving human embryos should be permitted under strict legal guidelines providing that such embryos do not develop beyond 14 days and are not implanted into a woman's or animal's body.
In recommending that SCNT be permitted under license, the Lockhart Review did emphasize concerns about the difficult issues surrounding human egg donation and the possibility of donor coercion, a situation that arose during the research of Woo-Suk Hwang in South Korea (Magnus and Cho, 2005; Steinbrook, 2006) . So strict guidelines were proposed to protect against such abuse. The Lockhart Review also reported several unexpected findings, such as that current legislation adversely impacted the practice of reproductive medicine (by restricting training of technicians for assisted reproductive technologies, and by effectively banning sperm competency tests that use mammalian eggs). A second unexpected issue was the lack of requests from researchers for creating human embryos for research by the union of sperm and egg, which is currently permitted in the UK under strict guidelines but not in Australia.
After considering the Lockhart Review, the Australian Prime Minister, John Howard, opposed adopting the committee's recommendations (Howard, 2006) . Within the Australian government, the split opinions of politicians seemed to reflect a similar split among the general public (Murphy, 2006) . Following considerable public debate, and equivalent debate by the cabinet and party room of the Government, the Prime Minister announced the highly unusual step of allowing all parliamentarians to take a conscience vote on any bill pertaining to adoption of amended legislation. Senator Kay Patterson, a former Health Minister, sponsored a Private Members Bill that sought to implement the reforms recommended by the Lockhart Review. In November of last year, the Senate narrowly voted in favor of the Bill, 34 votes to 32, although a key amendment was accepted in which SCNT using animal eggs would be prohibited. Last month, the Bill was presented to the House of Representatives, who voted 82 to 62 to accept the amended Bill.
Australia now has legislation, regulating research involving human embryos and SCNT, that is nationally more consistent and embracing than that in the US, where there are differing rules for private companies versus government-funded research and substantial differences between different states in the ability to conduct such work. In September of last year, President Bush vetoed a Bill passed by the US Senate that sought to loosen restrictions on federal funding for human embryonic stem cell research, indicating that current restrictions are likely to continue in the US (Bush, 2006) . Consistent with the British lead in liberal regulation of this research field, SCNT using donated human eggs will now be allowed in Australia (the new amendments take effect in June this year). By introducing a licensing system for researchers wishing to perform SCNT, Australia joins countries such as the UK, Belgium, and China. Granting licenses for research involving SCNT is seen as an option with greater built-in safeguards than, for example, allowing SCNT by not specifically prohibiting it (as is the case in South Korea). Consistent with community attitudes, the production of embryos by egg and sperm for research will not be permitted in Australia, although other countries such as the UK, Belgium, China, Cell 128, January 26, 2007 ©2007 Elsevier Inc. 223
Singapore, South Korea, and Sweden permit this.
By establishing clear and strict guidelines to permit the conduct of research involving human embryos in Australia, the incentive for researchers to move to other countries with less regulated ethical approaches is reduced. By adopting the recommendations of the Lockhart Review, Australia joins a cluster of other countries in providing a consistent national blueprint for responsible research involving human embryos.
